Balaji Amines reports Q2 FY27 consolidated revenue of ₹472 crore and PAT of ₹67 crore
Balaji Amines · Chemicals & Petrochemicals
Key highlights
- Q2 FY27 consolidated revenue ₹472 crore, EBITDA ₹106 crore, PAT ₹67 crore; volumes at 24,491 MT
- Commercial production commenced at expanded Acetonitrile facility, raising installed capacity to 1,440 TPM; 100,000 TPA DME plant commissioned
- Unit-I EDA derivatives expansion on track for end FY27 commissioning; Unit-II Chincholi HCN/EDTA plant targeted for Q4 FY27
Why it's rated major development: the year-on-year change is 81% (50% or more)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Balaji Amines
- Capex / expansionNotableBalaji Amines Ltd commissions expanded Acetonitrile plant on 24 Sept 2026
Other capex / expansion filings this fortnight
- ZF Steering Gear (India) reports unaudited Q2 and H1 results ended Sept 30, 2026
- ACME Solar commissions additional 66.68 MW solar capacity in Rajasthan
- AELEA Commodities Ltd announces Q2 financials, director changes, and business plans
- Lehar Footwears Q2FY27 revenue ₹100.1 crore vs ₹140.5 crore; PAT ₹4.6 crore vs ₹7.3 crore
- Shera Energy reports highest-ever H1FY27 revenue of ₹1047.4 Cr and PAT of ₹30.77 Cr
- Susan Electricals reports 190% revenue growth and ₹13.15 crore PAT in H1 FY27
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.